Inicio
Hormonas y cáncer
Andrógenos y cáncer de mama

8. Bibliografía


8.    Bibliografía

1.
A.M.H. Brodie, V.C.O. Njar. Aromatase inhibitors and their application in breast cancer treatment. Steroids 2000. 65: 171-179.
2.
K.A. Carolin KA, H.A. Pass. Prevention of breast cancer. Critical Reviews in Oncology and Hematology 2000. 33: 221-238.
3.
S.R. Davis. The therapeutic use of androgens in women. Journal of Steroid Biochemistry and Molecular Biology 1999. 69: 177-184.
4.
S.L. Davison, S.R. Davis. Androgens in women. Journal of Steroid Biochemistry and Molecular Biology 2003. 85: 363-366.
5.
C. Dimitrakakis, J. Zhou, C.A. Bondy. Androgens and mammary growth and neoplasia. Fertility and Sterility 2002. 77 (4, Suppl. 4): S26-S33.
6.
P. Ferro, M.G. Catalano, R. Dell'Eva, N. Fortunati, U. Pfeffer. The androgen receptor CAG repeat: a modifier of carcinogenesis?. Molecular and Cellular Endocrinology 2002. 193: 109-120.
7.
C.A. Haiman, M. Brown, S.E. Hankinson, D. Spiegelman, G.A. Colditz, W.C. Willett, P.W. Kantoff, D.J. Hunter. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. Cancer Research 2002. 62(4): 1045-9.
8.
D.J. Liao, R.J. Dickson. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. Journal of Steroid Biochemistry and Molecular Biology 2002. 80: 175-189.
9.
J.J. Park, R.A. Irvine, G. Buchanan, S.S. Koth, J.M. Park, W.D. Tilley, M.R. Stallcup, M.F. Press, G.A. Coetzee. Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor. Cancer Research 2000. 60: 5946-5949.
10.
R.J. Santen. Inhibition of aromatase: insights from recent studies. Steroids 2003. 68: 559-567.
11.
P. Vihko, P. Härkönen, O. Oduwole, S. Törn, R. Kurkela, A. Pulkka, V. Isomaa. 17$-Hydroxysteroid dehydrogenases and cancers. Journal of Steroid Biochemistry and Molecular Biology 2002. 83: 119-122.